caffeine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hock, BD | 1 |
| MacPherson, SA | 1 |
| McKenzie, JL | 1 |
| Svirnovski, AI | 1 |
| Serhiyenka, TF | 1 |
| Kustanovich, AM | 1 |
| Khlebko, PV | 1 |
| Fedosenko, VV | 1 |
| Taras, IB | 1 |
| Bakun, AV | 1 |
2 other studies available for caffeine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.
Topics: Caffeine; Cell Line, Tumor; Cell Proliferation; Humans; Immunity, Cellular; Leukemia, Lymphocytic, C | 2017 |
DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; ATP Binding Cassette Transporter, Sub | 2010 |